Serial analysis of the effects of methimazole or radical therapy on circulating CD16/56 subpopulations in Graves' disease.

The distribution of peripheral blood CD16/56 cytotoxic T and natural killer (NK) cells in Graves' disease patients is analyzed in order to correlate them with disease activity and with prognosis. Eighteen patients with Graves' disease, twenty-four patients with Hashimoto's thyroiditis and thirty-two sex- and age-matched healthy control subjects were studied. Peripheral blood CD16/56 (cytotoxic T and NK) cells were analyzed by cytofluorometry. A decreased proportion of CD16/56+ and CD16/ 56+CD3+ cells were detected in Graves' disease patients when compared with thyroiditis patients and healthy control groups. No correlation was detected with serum free thyroxine. On diagnosis, patients who would require a radical treatment for thyrotoxicosis control showed a significant decrease of cytotoxic CD56+ T (CD3+) and NK (CD3-) cells compared with those who would maintain the euthyroid state after methimazole. These results suggest that the cytotoxic compartment, both T and NK cells, of the immune system is altered in patients with Graves' disease, independently of the functional thyroid status. Changes in peripheral blood lymphocytes in Graves' disease patients could be useful as predictive markers of an unfavorable outcome.

[1]  A. Órfão,et al.  Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcohol liver disease but not active ethanol consumption , 1997, Hepatology.

[2]  A. Órfão,et al.  Serial analysis of the effects of methimazole therapy on circulating B cell subsets in Graves' disease. , 1996, The Journal of endocrinology.

[3]  F. Sánchez‐Madrid,et al.  Adhesion molecules from the LFA‐1/ICAM‐1, 3 and VLA‐4/VCAM‐1 pathways on T lymphocytes and vascular endothelium in Graves' and Hashimoto's thyroid glands , 1994, European journal of immunology.

[4]  R. Pujol-Borrell,et al.  γσ Lymphocytes in endocrine autoimmunity: evidence of expansion in Graves' disease but not in type 1 diabetes , 1993 .

[5]  R. Pujol-Borrell,et al.  Gamma delta lymphocytes in endocrine autoimmunity: evidence of expansion in Graves' disease but not in type 1 diabetes. , 1993, Clinical and Experimental Immunology.

[6]  F. Matsuzuka,et al.  Decreases in αβ T cell receptor negative T cells and CD8 cells, and an increase in CD4 + CD8+ cells in active Hashimoto's disease and subacute thyroiditis , 1992 .

[7]  F. Matsuzuka,et al.  Decreases in alpha beta T cell receptor negative T cells and CD8 cells, and an increase in CD4+ CD8+ cells in active Hashimoto's disease and subacute thyroiditis. , 1992, Clinical and Experimental Immunology.

[8]  A. Pinchera,et al.  The autoimmune infiltrate of Basedow's disease: analysis of clonal level and comparison with Hashimoto's thyroiditis. , 2009, Experimental and clinical endocrinology.

[9]  H. Ohashi,et al.  Circulating activated T cell subsets in autoimmune thyroid diseases: differences between untreated and treated patients. , 1991, Acta Endocrinologica.

[10]  A. Weetman,et al.  T cell receptor phenotypes in autoimmune thyroid disease , 1990, Journal of endocrinological investigation.

[11]  F. Matsuzuka,et al.  Marked increase of CD5 + B cells in hyperthyroid Graves' disease. , 1989, Clinical and experimental immunology.

[12]  F. Karlsson,et al.  Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells. , 1988, Clinical and experimental immunology.

[13]  N. Ishikawa,et al.  Natural killer and natural killer-like cell activity of peripheral blood and intrathyroidal mononuclear cells from patients with Graves' disease. , 1988, The Journal of clinical endocrinology and metabolism.

[14]  M. Fletcher,et al.  Suppression of peripheral blood natural killer cell activity by excess thyroid hormone. , 1987, The Journal of clinical investigation.

[15]  L. Lanier,et al.  The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. , 1986, Journal of immunology.

[16]  A. McGregor,et al.  Autoimmune thyroid disease: developments in our understanding. , 1984, Endocrine reviews.

[17]  R Volpé,et al.  Autoimmune thyroid disease. , 1984, Hospital practice.

[18]  H. Schleusener,et al.  Peripheral blood and intrathyroidal mononuclear cell populations in patients with autoimmune thyroid disorders enumerated using monoclonal antibodies. , 1983, The Journal of clinical endocrinology and metabolism.

[19]  Sidney H. Ingbar,et al.  The Thyroid Gland. , 1965 .

[20]  R. M.,et al.  The Thyroid Gland , 1894, Nature.